Amorphous dispersion Amorphous dispersion is a strategy used to improve the solubility and oral bioavailability of poorly water-soluble pharmaceutical compounds.
Chiral separations Chiral separations is a process used to separate a racemic mixture of two isomers into their constituent enantiomers.
Cocrystal development By forming cocrystals drug developers can modify the physical properties of an API while preserving the benefits of a crystalline solid form.
Crystallisation development Crystallisation development is an essential step utilised throughout the production of pharmaceutical drugs.
Physical and chemical analysis Assess the performance of novel crystalline forms, design-appropriate salt and cocrystal screens and investigate alternative drug delivery routes.
Polymorph screening Polymorph screening is the identification and characterisation of all relevant polymorphic forms of a pharmaceutical compound.
Salt screening Salt screening is a crucial step in modern drug development, as the presence of various salt forms can increase the dissolution rate and oral bioavailability of an API.
Battery materials Cathode battery materials, like our next generation ultra high energy density eLNO® and LIFE POWER® LFP, are the key to unlocking the potential of battery technology.
Buchwald palladacycle kit This kit contains a range of 2nd and 3rd generation Buchwald palladacycles that are air stable complexes and can be rapidly activated under mild conditions.
Home Products and services Markets View submenu Inspiring science Enhancing life View submenu About us Investors View submenu Media View submenu Careers View submenu EN
Go back one level Home Markets Automotive Chemicals Pharmaceutical and medical Oil and gas Agrochemicals and fertilisers Food and beverage Energy generation and storage Glass Other industries
Go back one level Home Enhancing life Our value chain Our sustainability framework Community investment Health and safety Policies, disclosures and position statements
Go back one level Home Investors Investors home Financial results Financial calendar Annual report AGM Presentations Shareholder information Share price charting Governance Analyst list Analysts' consensus Investor enquiries